SBIR/STTR Research Award

Characterization of Proteins and Their Aggregates at High Concentration

Award identifier bbc30e212dbc2f5b6bded1895c1b7703d3720408f24f704eb92a173599cdecc9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$156,482

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Scattering Solutions
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Scattering Solutions, LLC proposes to develop a method to characterize proteins and protein aggregation in highly concentrated suspensions by the combination of three new techniques: (1) cross correlation of light scattered within a single speckle to suppress the detrimental effect of multiple scattering; (2) optical homodyne amplification to suppress flare and errors arising from properties of the sample or its containment vessel; and (3) a new signal processing scheme to access a larger simultaneous dynamic range than formerly possible, with internally generated estimates of accuracy. Phase I research tasks build on previous research and development to confirm the feasibility of Scattering Solutions' light scattering technology for the characterization of highly concentrated proteins, and prepare for more advanced research and development which seeks to extend the range of measurements to include smaller sizes, dilute concentrations, small sample volumes, and shape characterization. This research specifically addresses stability issues which present efficacy and safety concerns to high concentration final dosage formulations of therapeutic agents. In addition, an investigation is proposed to examine the effect of protein concentration on fibril formation, a common structural feature in several degenerative conditions such as Parkinson and Alzheimer's diseases. This research addresses the aims of NIH in its objective to lay the foundation for advances in disease diagnosis, treatment, and prevention since it addresses an issue which is vital to patient care (drug administration), pharmaceutical development, and fundamental biochemistry and medical research. Phase II will yield the design and fabrication of an inexpensive yet versatile instrument with highly desirable capabilities not currently available. It will also include extensive studies with commercial therapeutic proteins provided by multiple collaborators, and studies concerning disease-correlated protein aggregation phenomena.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.